SARS-CoV-2 Surface Contamination in Cancer Centers ‘negligible’
NEW YORK (Reuters Health) – With strict infection-control protocols, surfaces in outpatient and inpatient hematology/oncology settings are unlikely to be
Read moreNEW YORK (Reuters Health) – With strict infection-control protocols, surfaces in outpatient and inpatient hematology/oncology settings are unlikely to be
Read moreA research review led by Oxford Brookes University has found a large proportion of COVID-19 survivors will be affected by
Read moreAdministering zinc supplements to COVID-19 patients with low levels of this element may be a strategy to reduce mortality and
Read moreAs the COVID-19 pandemic enters its second year, scientists are still working to understand how the new strain of coronavirus
Read moreNew research at Washington University School of Medicine in St. Louis indicates that three new, fast-spreading variants of the virus
Read moreBRUSSELS (Reuters) – The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a
Read moreInterim results presented here show the effectiveness of one dose of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines in preventing hospitalization of
Read moreNew research from UNC-Chapel Hill suggests that those who have previously experienced a SARS-CoV-2 infection develop a significant antibody response
Read moreTORONTO (Reuters) – Problems at AstraZeneca Plc’s European production site in January kicked off a six-week push to get a
Read moreTORONTO (Reuters) – Problems at AstraZeneca Plc’s European production site in January kicked off a six-week push to get a
Read more